<DOC>
	<DOCNO>NCT02025491</DOCNO>
	<brief_summary>Disseminated leishmaniasis ( DL ) emerge severe form leishmaniasis , increase prevalence Bahia , Brasil . It characterize multiple acneiform , papular ulcerated lesion localize face , chest , abdomen extremity . The number lesion range 10 hundred , mucosal disease document 40 % case . DL hard cure disease therapeutic failure pentavalent antimony document 70 % case cause L. braziliensis endemic area Corte de Pedra , Bahia . The majority DL patient need several course antimony use high dose Amphotericin B desoxicolate cure . Therefore DL patient expose relevant drug toxicity , high morbidity due long lasting disease , important socio-economic impact . Our hypothesis liposomal Amphotericin B high cure rate historic cure rate pentavalent antimony treatment disseminate leishmaniasis .</brief_summary>
	<brief_title>Liposomal Amphotericin Disseminated Leishmaniasis</brief_title>
	<detailed_description />
	<mesh_term>Leishmaniasis</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<criteria>) clinical diagnosis Disseminated Leishmaniasis accord case definition ; b ) illness duration less three month , c ) parasite identification culture polymerase chain reaction method , ) previous treatment leishmaniasis . ) immunodeficiency antibody HIV , b ) pregnancy patient willing unable use contraceptives 3 month end therapy c ) ALT , AST ≥3x normal reference value , creatinine BUN ≥1.5x normal reference value , ) evidence serious underlying disease ( cardiac , renal , hepatic , pulmonary ) include serious infection DL .</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Disseminated leishmaniasis</keyword>
	<keyword>Liposomal Amphotericin B</keyword>
	<keyword>Leishmania braziliensis</keyword>
</DOC>